Moderna, Inc.
MRNA
$59.81
$0.641.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -73.30% | -45.51% | |||
| Total Other Revenue | 37.84% | 15.63% | |||
| Total Revenue | -62.72% | -42.63% | |||
| Cost of Revenue | 1.65% | -40.83% | |||
| Gross Profit | -75.96% | 38.62% | |||
| SG&A Expenses | 24.86% | -43.83% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.12% | -41.43% | |||
| Operating Income | -58.63% | 40.49% | |||
| Income Before Tax | 42.50% | -66.96% | |||
| Income Tax Expenses | 66.67% | -66.67% | |||
| Earnings from Continuing Operations | 41.77% | -62.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.77% | -62.59% | |||
| EBIT | -58.63% | 40.49% | |||
| EBITDA | -65.41% | 42.91% | |||
| EPS Basic | 42.21% | -61.36% | |||
| Normalized Basic EPS | -66.00% | 43.35% | |||
| EPS Diluted | 42.21% | -61.36% | |||
| Normalized Diluted EPS | -66.00% | 43.35% | |||
| Average Basic Shares Outstanding | 0.76% | 0.77% | |||
| Average Diluted Shares Outstanding | 0.76% | 0.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||